Literature DB >> 21087707

Urban particulate matter air pollution is associated with subclinical atherosclerosis: results from the HNR (Heinz Nixdorf Recall) study.

Marcus Bauer1, Susanne Moebus, Stefan Möhlenkamp, Nico Dragano, Michael Nonnemacher, Miriam Fuchsluger, Christoph Kessler, Hermann Jakobs, Michael Memmesheimer, Raimund Erbel, Karl-Heinz Jöckel, Barbara Hoffmann.   

Abstract

OBJECTIVES: The aim of this study was to investigate the association of long-term residential exposure to fine particles with carotid intima-media thickness (CIMT).
BACKGROUND: Experimental and epidemiological evidence suggest that long-term exposure to air pollution might have a causal role in atherogenesis, but epidemiological findings are still inconsistent. We investigate whether urban particulate matter (PM) air pollution is associated with CIMT, a marker of subclinical atherosclerosis.
METHODS: We used baseline data (2000 to 2003) from the HNR (Heinz Nixdorf Recall) study, a population-based cohort of 4,814 participants, 45 to 75 years of age. We assessed residential long-term exposure to PM with a chemistry transport model and measured distance to high traffic. Multiple linear regression was used to estimate associations of air pollutants and traffic with CIMT, adjusting for each other, city of residence, age, sex, diabetes, and lifestyle variables.
RESULTS: Median CIMT of the 3,380 analyzed participants was 0.66 mm (interquartile range 0.16 mm). An interdecile range increase in PM(2.5) (4.2 μg/m(3)), PM(10) (6.7 μg/m(3)), and distance to high traffic (1,939 m) was associated with a 4.3% (95% confidence interval [CI]: 1.9% to 6.7%), 1.7% (95% CI: -0.7% to 4.1%), and 1.2% (95% CI: -0.2% to 2.6%) increase in CIMT, respectively.
CONCLUSIONS: Our study shows a clear association of long-term exposure to PM(2.5) with atherosclerosis. This finding strengthens the hypothesized role of PM(2.5) as a risk factor for atherogenesis.
Copyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21087707     DOI: 10.1016/j.jacc.2010.04.065

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  67 in total

Review 1.  Environmental factors in cardiovascular disease.

Authors:  Kristen E Cosselman; Ana Navas-Acien; Joel D Kaufman
Journal:  Nat Rev Cardiol       Date:  2015-10-13       Impact factor: 32.419

2.  Air quality, stroke, and coronary events: results of the Heinz Nixdorf Recall Study from the Ruhr Region.

Authors:  Barbara Hoffmann; Gudrun Weinmayr; Frauke Hennig; Kateryna Fuks; Susanne Moebus; Christian Weimar; Nico Dragano; Dirk M Hermann; Hagen Kälsch; Amir A Mahabadi; Raimund Erbel; Karl-Heinz Jöckel
Journal:  Dtsch Arztebl Int       Date:  2015-03-20       Impact factor: 5.594

3.  Expert position paper on air pollution and cardiovascular disease.

Authors:  David E Newby; Pier M Mannucci; Grethe S Tell; Andrea A Baccarelli; Robert D Brook; Ken Donaldson; Francesco Forastiere; Massimo Franchini; Oscar H Franco; Ian Graham; Gerard Hoek; Barbara Hoffmann; Marc F Hoylaerts; Nino Künzli; Nicholas Mills; Juha Pekkanen; Annette Peters; Massimo F Piepoli; Sanjay Rajagopalan; Robert F Storey
Journal:  Eur Heart J       Date:  2014-12-09       Impact factor: 29.983

Review 4.  Association between fine particulate matter exposure and subclinical atherosclerosis: A meta-analysis.

Authors:  Emmanuel Akintoye; Liuhua Shi; Itegbemie Obaitan; Mayowa Olusunmade; Yan Wang; Jonathan D Newman; John A Dodson
Journal:  Eur J Prev Cardiol       Date:  2015-05-29       Impact factor: 7.804

5.  Five-year exposure to PM2.5 and ozone and subclinical atherosclerosis in late midlife women: The Study of Women's Health Across the Nation.

Authors:  Chunzhe Duan; Evelyn Talbott; Maria Brooks; Sung Kyun Park; Rachel Broadwin; Karen Matthews; Emma Barinas-Mitchell
Journal:  Int J Hyg Environ Health       Date:  2018-09-17       Impact factor: 5.840

6.  Residential Exposure to PM2.5 and Ozone and Progression of Subclinical Atherosclerosis Among Women Transitioning Through Menopause: The Study of Women's Health Across the Nation.

Authors:  Chunzhe Duan; Evelyn O Talbott; Rachel Broadwin; Maria Brooks; Karen Matthews; Emma Barinas-Mitchell
Journal:  J Womens Health (Larchmt)       Date:  2019-02-07       Impact factor: 2.681

Review 7.  The "New Deadly Quartet" for cardiovascular disease in the 21st century: obesity, metabolic syndrome, inflammation and climate change: how does statin therapy fit into this equation?

Authors:  Michael Clearfield; Melissa Pearce; Yasmin Nibbe; David Crotty; Alesia Wagner
Journal:  Curr Atheroscler Rep       Date:  2014-01       Impact factor: 5.113

8.  Ambient air pollution and racial/ethnic differences in carotid intima-media thickness in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Miranda R Jones; Ana V Diez-Roux; Marie S O'Neill; Eliseo Guallar; A Richey Sharrett; Wendy Post; Joel D Kaufman; Ana Navas-Acien
Journal:  J Epidemiol Community Health       Date:  2015-07-03       Impact factor: 3.710

9.  Associations between ambient air pollution and Hypertensive Disorders of Pregnancy.

Authors:  Zahra Mobasher; Muhammad T Salam; T Murphy Goodwin; Frederick Lurmann; Sue A Ingles; Melissa L Wilson
Journal:  Environ Res       Date:  2013-03-21       Impact factor: 6.498

10.  Prospective study of particulate air pollution exposures, subclinical atherosclerosis, and clinical cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air).

Authors:  Joel D Kaufman; Sara D Adar; Ryan W Allen; R Graham Barr; Matthew J Budoff; Gregory L Burke; Adrian M Casillas; Martin A Cohen; Cynthia L Curl; Martha L Daviglus; Ana V Diez Roux; David R Jacobs; Richard A Kronmal; Timothy V Larson; Sally Lee-Jane Liu; Thomas Lumley; Ana Navas-Acien; Daniel H O'Leary; Jerome I Rotter; Paul D Sampson; Lianne Sheppard; David S Siscovick; James H Stein; Adam A Szpiro; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2012-10-04       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.